News
May 11, 2026: Connecticut AG’s crackdown leads to major platform halting sales of “research grade” weight loss chemicals to U.S.
In a major settlement, Made-in-China.com will stop selling research chemicals to U.S. buyers following an investigation by Connecticut’s Attorney General.
[...]May 4, 2026: FDA moves to restrict large-scale compounding of three weight loss drugs
The FDA proposed restricting three GLP-1 drugs from the 503B bulks list, which would prevent outsourcing facilities from compounding them from raw ingredients without a clear clinical need.
[...]Partnership for Safe Medicines Applauds FDA Action to Curb Unsafe Compounding of GLP-1 Medications
The Partnership for Safe Medicines strongly supports the Food and Drug Administration’s proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list. This action reflects sound science, sound law, and a clear-eyed commitment to patient safety. Full statement inside.
[...]April 27, 2026: Physician who illegally imported weight loss drugs gets probation
The former doctor admitted to buying tirzepatide from a lab in China and distributing it without medical evaluations, and is now being sued by a former hospital employee who alleges the drug caused life-threatening complications requiring major surgery.
[...]Prescription Drug Freight Fraud Report, April 2026
What do FDA records of GLP-1 and antibiotic imports show about freight fraud patterns over the last six months?
[...]What’s master carton smuggling?
In March, customs officers in Cincinnati announced the seizure of thousands of shipments of GLP-1s and other peptides packaged inside more than 300 “master cartons” with deceptive manifests meant to slip into the country unnoticed. Curious how this smuggling scheme works? Read on.
[...]April 20, 2026: Maryland becomes the second state to set a drug price cap
The Jardiance upper payment limit, based on the Medicare maximum fair price, is set to take effect in 2027.
[...]April 13, 2026: New video shows Mochi Health-affiliated pharmacy’s “corner cutting”
A newly-released March 2025 Washington State Department of Health video shows investigators raiding Aequita, where “cutting corners [was seen] at nearly every level of its operation.”
[...]The FDA speaks up about AFPs and drug importation
Is personal drug importation legal in the context of alternative funding programs? The FDA says no.
Are self-funded health plans allowed to import medicine because of “Section 804” or “Florida’s importation plan”? Also, no.
[...]April 6, 2026: Over 200 patients bought unapproved imported peptides from a now-indicted Utah physician
The doctor allegedly bought the unapproved drugs through a middleman and relabeled them before selling them to patients.
[...]